IQ Consortium Member Companies
Membership in IQ is open to any corporation and/or any subsidiary thereof which is significantly engaged in the development of new chemical entities or new molecular entities for the prevention, diagnosis or treatment of disease. For information about joining the Consortium, please see Join IQ.
Current IQ Consortium members include:
|
AbbVie Agios Alnylam Amgen, Inc. Amicus Therapeutics Astellas AstraZeneca Bayer HealthCare BeiGene Bill & Melinda Gates MRI Biogen Blueprint Medicines Boehringer Ingelheim Bristol Myers Squibb CSL Behring Daiichi Sankyo
|
Eisai, Inc. Eli Lilly and Company EMD Serono Erasca, Inc. F. Hoffmann-La Roche Genentech Gilead Sciences GSK PLC Idorsia Incyte Corporation Janssen Merck & Co., Inc. Mitsubishi Tanabe Moderna Therapeutics Novartis Novo Nordisk
|
Organon Orion Corporation, Otsuka Pfizer Regeneron Relay Therapeutics Sanofi Sarepta Seagen Servier Sumitomo Pharma America (SMPA) Takeda Teva UCB Pharma Vertex, Inc. Xencor
|